• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
material safety data sheet - Boehringer Ingelheim Vetmedica
material safety data sheet - Boehringer Ingelheim Vetmedica

... Atgard® Swine Wormer is designed to be administered to swine in limited amounts of a mealtype (non-pelleted ration). When used according to the directions, the active ingredient (dichlorvos) release rate is sufficient to provide for high anthelmintic efficiency but not of such magnitude as to exceed ...
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

... excipients or products. This allows each company to determine which solvents it uses in production and develop testing procedures that address their specific needs. It is the responsibility of the drug manufacturer to qualify the purity of all the components used in the manufacturing of the drug pro ...
Division of Clinical Pharmacology Department of Medicine and Health Sciences Linköping University
Division of Clinical Pharmacology Department of Medicine and Health Sciences Linköping University

... literature, 30 were classified as signals and 50 as not signals. The performance of the semiautomated and the clinical algorithm were comparable. In the end the clinical algorithm was chosen. At a relevant level, 38% were of the adverse drug interactions were already known in the literature and of t ...
EXTEMPORANEOUS PREPARATION OF PAEDIATRIC ORAL
EXTEMPORANEOUS PREPARATION OF PAEDIATRIC ORAL

Typical Scabies vs Crusted Scabies Human scabies is caused by an
Typical Scabies vs Crusted Scabies Human scabies is caused by an

Management of Grapefruit-Drug Interactions
Management of Grapefruit-Drug Interactions

... affect the metabolism of many medications, increasing the risk of toxicity and adverse effects. Characteristics of oral medications that may interact with grapefruit include extensive metabolism through the intestinal cytochrome P450 3A4 system, low bioavailability, and a narrow therapeutic index. P ...
Minireview Low-Turnover Drug Molecules: A Current Challenge for
Minireview Low-Turnover Drug Molecules: A Current Challenge for

... approach is well-established, it requires access to often intractable authentic metabolite standards for calibration curve generation, which is typically not supported until early human clinical studies when predominant circulating metabolites are identified. Nonetheless, methodologies such as quant ...
13274025
13274025

... Generic Medicine: Generic means a medicine based on an active substance that is out of patent and which is marketed under a different name from that of the original branded medicine. ...
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB

... The following studies were excluded: 1) case reports with ,five cases, editorials and reviews on linezolid; 2) laboratory studies; 3) animal studies; and 4) studies where MDR-TB and XDR-TB were not confirmed by M. tuberculosis culture and drug susceptibility testing (DST) in quality-assured laborato ...
senate report 103-97
senate report 103-97

... from nuclear, biological, and chemical weapons or other dangerous substances during wartime. In the Persian Gulf War, U.S. troops were intentionally exposed to an investigational vaccine that was intended to protect them against biological warfare, and they were given pyridostigmine bromide pills in ...
WHO Drug Dictionaries Best Practices v2
WHO Drug Dictionaries Best Practices v2

world preview 2014, outlook to 2020
world preview 2014, outlook to 2020

Common Goat Medications and "Easy to Understand" Dosages
Common Goat Medications and "Easy to Understand" Dosages

JUL -9 2235 ‘Y?
JUL -9 2235 ‘Y?

... Appendix 2 of the new information sent May 18, 1998), BioResponse contacted 2 physicians directly supervising 13C supplementation. These responses from physicians following and evaluating RRP patients on 13C supplementation are summarized in Appendix 111, These patients have been adding encapsulated ...
Reaction of Homopiperazine with Endogenous Formaldehyde: A
Reaction of Homopiperazine with Endogenous Formaldehyde: A

... the In Vivo Samples. Typically, in early in vivo metabolite identification studies, temporal blood and urine samples are typically combined to obtain a single pooled sample for each matrix. The sample is then analyzed on a LC-UV-MS/MS system in conjunction with a predose sample spiked with analyte t ...
Astaxanthin - Pure Encapsulations
Astaxanthin - Pure Encapsulations

... Are There Any Potential Drug Interactions? At this time, there are no known adverse reactions when taken in conjunction with medications. ...
CRS Newsletter. Volume 25, Number 2. 2008
CRS Newsletter. Volume 25, Number 2. 2008

... ver the past year the CRS Board of Directors has developed a new CRS strategic plan that specifies goals and objectives, along with current priorities for achieving these objectives. I would like to highlight some of our activities and the progress that has been made on some of the strategic initiat ...
Review on Prodrugs
Review on Prodrugs

Mechanism-based Inhibition: Deriving KI and kinact
Mechanism-based Inhibition: Deriving KI and kinact

Practicalities in the Use of Obesity Pharmacologic Agents
Practicalities in the Use of Obesity Pharmacologic Agents

FORMULATION AND EVALUATION OF FAST DISINTIGRATING MELOXICAM TABLETS AND ITS  COMPARISON WITH MARKETED PRODUCT 
FORMULATION AND EVALUATION OF FAST DISINTIGRATING MELOXICAM TABLETS AND ITS  COMPARISON WITH MARKETED PRODUCT 

... weight. The weight variation in all the six formulations was found to  be  199.98  to  202.15  mg,  which  was  in  pharmacopoeial  limits  of  ±7.5% of the average weight. The percentage drug content of all the  tablets was found to be between  91.43 ±  0.54 to 99.18 ±  0.32 %  of  Meloxicam which  ...
Pharmaceutical excipients and pediatric formulations
Pharmaceutical excipients and pediatric formulations

... with the API or interact with intracellular chemicals to produce adverse Similarly, distribution of drugs can be severely impacted in pediatric reactions. The interactions thus produced due to drug-excipient, sub-population as the amount of body water is significantly higher excipient-excipient, or ...
Sucralose Safety Backgrounder
Sucralose Safety Backgrounder

... The safety of sucralose is documented by one of the most extensive and thorough safety testing programs ever conducted on a new food additive. More than 100 studies conducted and evaluated over a 20-year period clearly demonstrate the safety of sucralose. Studies were conducted in a broad range of a ...
1. NAME OF THE MEDICINAL PRODUCT Dompicare 20 mg, film
1. NAME OF THE MEDICINAL PRODUCT Dompicare 20 mg, film

... is eliminated mainly by metabolism and therefore, caution is recommended in patients with hepatic impairment, see sections 4.2, 4.4. Renal impairment In patients with severe renal impairment (GFR <30 ml/min/1.73 m2) the elimination half-life of domperidone was increased from 7.4 to 20.8 hours, but p ...
Prodrugs—from Serendipity to Rational Design
Prodrugs—from Serendipity to Rational Design

... The latter are usually referred to as bioprecursor prodrugs. Conventional carrier-linked prodrugs often have a synthetic handle, a spacer or linker, between the active drug and the promoiety when the desired prodrug moiety cannot be attached directly to the parent molecule because of steric hindranc ...
< 1 ... 12 13 14 15 16 17 18 19 20 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report